MMJ PhytoTech Ltd (ASX:MMJ) Company Update - Q&A Session with Managing Director
MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide shareholders with this Q&A update from Managing Director Andreas Gedeon.
Companies in the News
Drugs & OTC
Higher Price Target for Ocera Therapeutics (NASDAQ:OCRX) as Hepatic Encephalopathy Treatment Study Moves Forward
An innovative potential treatment for hepatic encephalopathy created by Ocera Therapeutics, Inc. (NASDAQ:OCRX) is a unique product on an under-served market, and if clinical trials are successful, it could become a major source of success and profitability for the company, according to an Aegis Capital Corp. report (http://nnw.fm/cNkZ1) released on December 8. The report reiterates a 'Buy' rating for Ocera and recommends a higher stock price target of $8, compared to the $2.1 at the time of the analysis.
Rennova Health, Inc. (NASDAQ:RNVA) Creating the Next Generation of Health Care
Rennova Health, Inc. (NASDAQ:RNVA, RNVAX), a vertically integrated public holding company serving the health care sector, focuses on offering comprehensive single-source solutions to health care providers ranging from diagnostic laboratory testing to technology solutions, revenue cycle management and financial and billing services. With a declared goal of creating efficient, innovative and empowering solutions, the company is dedicated to putting the needs of health care providers and their patients at the center of everything it does.
MMJ PhytoTech Ltd (ASX:MMJ) Canadian Government Submits Report on Cannabis Legalisation
MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the below statement following the Canadian Federal Government's Final Report into Cannabis Legalization and Regulation. The Report has been based on the findings and recommendations submitted by the Health Canada instigated Task Force.
MMJ PhytoTech Ltd (ASX:MMJ) Signs Definitive Agreement with Harvest One (CVE:WON)
MMJ PhytoTech Ltd (ASX:MMJ) today confirms that it has signed a definitive agreement with Canadian-based Harvest One Capital Corp. (CVE:WON). The definitive agreement outlines the sale of 100% of issued and outstanding shares of United Greeneries Holdings Ltd and Satipharm AG to Harvest One.
Heron Therapeutics (HRTX) Helps Chemo Patients Prevent Vomiting with SUSTOL(R)
Cancer is the great scourge of our age. This year, 1.7 million Americans will find out they have the disease and some 600,000 will die from it. In total, approximately 40 percent of the population can expect to be diagnosed with cancer during their lifetime. The name "cancer" is derived from the Greek word for crab and may have been bestowed to indicate the tenacity of the disorder. Cancer tends to persist with the same relentlessness as the claws of a crab cling to a victim.
European Patent Dispute Spurs Buying Opportunity with Higher Price Target for Alder Biopharmaceuticals (ALDR)
A legal dispute with the European Patent Office over the European patent for its lead product candidate surprisingly presents a strong buying opportunity for clinical stage biopharmaceutical company Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR), according to an analysis report (http://nnw.fm/8j0TO) released by Aegis Capital Corp on November 23. As such, Aegis analysts reiterated a 'Buy' rating for the company and proposed a higher stock price target of $41, compared to the $25.28 stock price at the time the report was issued.
◂Previous Page
Drugs & OTC Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Managing Director and CEO Commencement Date
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
- Central Petroleum Limited (ASX:CTP) Sub-Salt Exploration Permit Sale Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Canadian Patent Secured for PromarkerEso Test for Esophageal Adenocarcinoma
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of CEO and Managing Director
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published
Social Media
